Invention Grant
- Patent Title: Factor IXa inhibitors
-
Application No.: US15303322Application Date: 2015-04-10
-
Publication No.: US09808445B2Publication Date: 2017-11-07
- Inventor: Isao Sakurada , Tomokazu Hirabayashi , Yoshitaka Maeda , Hiroshi Nagasue , Takashi Mizuno , Jiayi Xu , Ting Zhang , Cameron Smith , Dann Parker
- Applicant: Merck Sharp & Dohme Corp. , Mochida Pharmaceutical Co., Ltd.
- Applicant Address: US NJ Rahway JP Tokyo
- Assignee: Merck Sharp & Dohme Corp.,Mochida Pharmaceutical Co., Ltd.
- Current Assignee: Merck Sharp & Dohme Corp.,Mochida Pharmaceutical Co., Ltd.
- Current Assignee Address: US NJ Rahway JP Tokyo
- Agent Nicole M. Beeler; Catherine D. Fitch
- International Application: PCT/US2015/025219 WO 20150410
- International Announcement: WO2015/160634 WO 20151022
- Main IPC: A61K31/501
- IPC: A61K31/501 ; A61K31/439 ; C07D413/14 ; C07D261/20 ; C07D413/04 ; C07D498/04 ; C07D209/52 ; C07D519/00 ; A61K31/444 ; A61K31/506 ; A61K45/06

Abstract:
In its many embodiments, the present invention provides a novel class of benzamide compounds represented by Formula (I) or pharmaceutically acceptable salts or solvates thereof, or pharmaceutical compositions comprising one or more said compounds or pharmaceutically acceptable salts or solvates thereof, and methods for using said compounds or pharmaceutically acceptable salts or solvates thereof for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes.
Public/Granted literature
- US20170027916A1 FACTOR IXa INHIBITORS Public/Granted day:2017-02-02
Information query
IPC分类: